OncoQuest Completes US $6M Private Placement
EDMONTON, ALBERTA, February 6, 2018 - OncoQuest Inc. (“OncoQuest”), a biopharmaceutical company focused on the development and commercialization of immunotherapeutic products for the treatment of cancer, today announced completion of a private placement financing which raised US$6.03 million. The financing was led by a South Korean institutional fund. Under the private placement, the Company issued 603,000 common shares at US$10.00 share.